https://blog.lifesciencenation.com/2026/06/09/hot-investor-mandate-life-sciences-platform-invests-up-to-20m-in-early-stage-therapeutics-diagnostics-and-medical-technologies/Next Phase Newsletteren2026-06-09T16:15:35+00:00Hot Investor Mandate: Life Sciences Platform Invests Up to $20M in Early-Stage Therapeutics, Diagnostics, and Medical Technologiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/06/09/hot-investor-mandate-healthcare-focused-investment-firm-deploys-10m-initial-checks-in-seed-to-series-b-biopharmaceutical-companies/Next Phase Newsletteren2026-06-09T16:15:16+00:00Hot Investor Mandate: Healthcare-Focused Investment Firm Deploys $10M Initial Checks in Seed to Series B Biopharmaceutical Companiestechnology, health, AI, business, entrepreneurship, finance, investinghttps://blog.lifesciencenation.com/2026/06/09/hot-investor-mandate-european-healthtech-vc-invests-up-to-e5m-in-seed-and-series-a-companies-with-commercial-traction/Next Phase Newsletteren2026-06-09T16:14:57+00:00Hot Investor Mandate: European HealthTech VC Invests Up to €5M in Seed and Series A Companies with Commercial Tractiontechnology, health, business, entrepreneurship, finance, investinghttps://blog.lifesciencenation.com/2026/06/09/hot-investor-mandate-europe-based-vc-firm-invests-e-1-3m-in-technologies-addressing-diabetes-and-chronic-disease-conditions/Next Phase Newsletteren2026-06-09T16:14:37+00:00Hot Investor Mandate: Europe-Based VC Firm Invests € 1-3M in Technologies Addressing Diabetes and Chronic Disease Conditions technology, health, business, entrepreneurship, finance, investing